Skip to main content
Fig. 1 | Thrombosis Journal

Fig. 1

From: Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis

Fig. 1

Model diagram. Abbreviations: DOACs, direct oral anticoagulants; LMWHs, low molecular weight heparins; onAC, on anticoagulation treatment with no event; rDVT, recurrent deep-vein thrombosis; rPE, recurrent pulmonary embolism; ICH, intracranial hemorrhage; CRNMB, clinically relevant non-major bleeding; offAC, anticoagulant treatment discontinuation; offDVT, risk of deep-vein thrombosis while off-treatment; offPE: risk of pulmonary embolism while off-treatment

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us